Nautilus Biotechnology, Inc. (NAUT)
NASDAQ: NAUT · Real-Time Price · USD
2.280
-0.070 (-2.98%)
At close: Jun 10, 2026, 4:00 PM EDT
2.260
-0.020 (-0.88%)
After-hours: Jun 10, 2026, 4:10 PM EDT
Nautilus Biotechnology Market Cap
Nautilus Biotechnology has a market cap or net worth of $289.74 million as of June 10, 2026. Its market cap has increased by 192.96% in one year.
Market Cap
289.74M
Enterprise Value
232.27M
1-Year Change
192.96%
Ranking
Category
Stock Price
$2.28
Market Cap Chart
Since March 26, 2021, Nautilus Biotechnology's market cap has increased from $117.04M to $289.74M, an increase of 147.57%. That is a compound annual growth rate of 19.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 8, 2026 | 296.09M | 20.22% |
| Dec 31, 2025 | 246.29M | 16.76% |
| Dec 31, 2024 | 210.95M | -43.54% |
| Dec 29, 2023 | 373.66M | 66.44% |
| Dec 30, 2022 | 224.50M | -65.10% |
| Dec 31, 2021 | 643.18M | 449.56% |
| Mar 26, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lineage Cell Therapeutics | 311.62M |
| Abeona Therapeutics | 310.05M |
| DiaMedica Therapeutics | 309.83M |
| Silence Therapeutics | 309.39M |
| Neumora Therapeutics | 306.92M |
| Fennec Pharmaceuticals | 305.69M |
| Lyell Immunopharma | 303.66M |
| Invivyd | 300.50M |